DivestmentAug 6, 2026, 04:21 PM
Health Catalyst Divests Vitalware for $147M, Repays Debt
AI Summary
Health Catalyst completed the divestiture of its Vitalware business to Med-Metrix, LLC for $147 million on July 31, 2026. The company used the proceeds, along with cash on hand, to fully repay and terminate its credit facility, eliminating approximately $19 million in annual interest expense and sharpening its strategic focus. For Q2 2026, Health Catalyst reported total revenue of $70.487 million, a net loss of $(40.537) million, and Adjusted EBITDA of $9.919 million, exceeding revenue guidance.
Key Highlights
- Divestiture of Vitalware business completed for $147 million cash.
- Credit facility debt fully repaid, eliminating $19 million in annual interest expense.
- Q2 2026 total revenue decreased 13% year-over-year to $70.487 million.
- Q2 2026 net loss was $(40.537) million, a 1% improvement year-over-year.
- Q2 2026 Adjusted EBITDA increased 6% year-over-year to $9.919 million.
- Q3 2026 revenue guidance set at $55 million to $56 million.
- Full year 2026 revenue guidance set at $246 million to $249 million.
Price Impact
More from HCAT